Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The method can effectively extract biomedical information without needing expert annotation, performing better than previous models.

The Rotterdam Study aims to understand various diseases in older adults.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.